US EditionAurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
- Aurora Cannabis Inc. has denied the incorrect claim about acquiring MedLeaf Therapeutics, stating it has had no such discussions or agreements.
- The company emphasized that there has been no statement or information filed regarding a transaction with MedLeaf Therapeutics.
- Earlier today, Aurora filed its financial statements for the fourth quarter and fiscal year ending March 31, 2025.
- Aurora serves both medical and consumer cannabis markets across multiple regions, emphasizing its focus on science and innovation.
50 Articles
50 Articles
Aurora Cannabis Denounces AI‑Generated Reports Claiming $215 Million Acquisition and European Deal, Shares Drop 20%
Aurora Cannabis Inc. says a pair of AI‑generated articles that surfaced online this week—one alleging a $215 million takeover of a New Zealand marijuana producer—are entirely false. The stories appeared Wednesday on financial news site Investing.com but were removed by Thursday afternoon after the Edmonton‑based company flagged the inaccuracies. “Neither of these stories are true in any … Continue reading
Aurora Cannabis clears the air and denies MedLeaf acquisition news
Aurora Cannabis (TSX:ACB) issued a firm denial of recent misinformation circulating online regarding alleged acquisitions and strategic partnerships The company became aware of an article posted on a news website falsely claiming that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics A second article incorrectly reported that Aurora had signed a partnership with MediPharm (TSX:LABS) distribute medical cannabis in Germany and ot…
Aurora Cannabis Inc. Denies Acquisition Of MedLeaf Therapeutics - Canadian Manufacturing
EDMONTON — Aurora Cannabis Inc. says it has become aware of “misinformation” posted on a news website, incorrectly stating that Aurora has agreed to acquire New Zealand based MedLeaf Therapeutics. The Company says it has not entered into any such agreement, has had no discussions with MedLeaf Therapeutics with respect to any business combination transaction, and has not made any statement or filed any information pertaining to any such transacti…
Coverage Details
Bias Distribution
- 73% of the sources are Center
To view factuality data please Upgrade to Premium
